The current prices are delayed, login to your account for live prices
LOGIN
Create Alert
Watchlist

Aurobindo Pharma

1148.50
+11.50 (1.01%) 1D
NSE
1D
1W
1M
3M
6M
1Y
3Y
5Y
All
Overview
News
Events
F&O

Performance

Open
1,143.00
Prev. Close
1,137.00
Volume
2,13,465
Total traded value
24.52 Cr
Upper Circuit
1,250.70
Lower Circuit
1,023.30

Analyst Estimates

56%
Buy
56%
Hold
28%
Sell
16%
Aggregated by Refinitiv from 25 Analysts

Fundamentals

Market Cap₹66,630Cr
ROE11.60%
P/E Ratio(TTM)19.09
EPS(TTM)59.58
P/B Ratio2.16
Dividend Yield0.40%
Industry P/E32.81
Book Value527.00
Debt to Equity0.27
Face Value1
Understand Fundamentals

Financials

Revenue
Profit
Net Worth
*All values are in Rs. Cr
7,5147,7167,7887,9328,136Dec '23Mar '24Jun '24Sep '24Dec '24
Quarterly
Yearly

About Aurobindo Pharma

Aurobindo Pharma Limited is an India-based pharmaceutical company. The Company is principally engaged in manufacturing and marketing of active pharmaceutical ingredients, branded pharmaceuticals, generic pharmaceuticals and related services. Its product portfolio is spread over seven therapeutic/product areas encompassing Central nervous systems (CNS), Antiretrovirals (ARVs), Cardiovascular (CVS), SSP - Orals & Sterile, Anti-infectives, Anti-diabetics and Cephalosporins - Orals. It is engaged in developing a range of oncology and hormonal products. It is developing topical as well as transdermal products in the dermatology therapeutic segment. It is also developing about three depot injections based on the microsphere and nano-suspension technology platforms. The Company is marketing its products globally in approximately 150 countries. The Company's subsidiaries include APL Healthcare Limited, Auronext Pharma Private Limited, Auro Peptides Limited, APL Pharma Thai Limited, and others.;
Parent OrganisationAurobindo Pharma Limited
Managing DirectorMr. K. Nityananda Reddy
NSE SymbolAUROPHARMA

Shareholding Pattern

Dec '23
Mar '24
Jun '24
Sep '24
Dec '24
Promoters
51.82%
Mutual Funds
17.81%
Foreign Institutions
16.29%
Other Domestic Institutions
7.39%
Retail And Others
6.69%

Similar Stocks

COMPANY
52 WEEK
MARKET PRICE
P/E Ratio
Sun Pharmaceutical Industries
NA
(0.00%)
36.70
Cipla
NA
(0.00%)
24.42
Dr Reddy's Laboratories
NA
(0.00%)
18.09
Lupin
NA
(0.00%)
32.39
Groww
Want to invest in this stock?
Open a free Demat account in minutes to start investing in stocks.
ⓒ 2016-2025 Groww. All rights reserved, Built with in India
MOST POPULAR ON GROWWVERSION - 5.8.9
STOCK MARKET INDICES:  S&P BSE SENSEX |  S&P BSE 100 |  NIFTY 100 |  NIFTY 50 |  NIFTY MIDCAP 100 |  NIFTY BANK |  NIFTY NEXT 50
MUTUAL FUNDS COMPANIES:  GROWWMF |  SBI |  AXIS |  HDFC |  UTI |  NIPPON INDIA |  ICICI PRUDENTIAL |  TATA |  KOTAK |  DSP |  CANARA ROBECO |  SUNDARAM |  MIRAE ASSET |  IDFC |  FRANKLIN TEMPLETON |  PPFAS |  MOTILAL OSWAL |  INVESCO |  EDELWEISS |  ADITYA BIRLA SUN LIFE |  LIC |  HSBC |  NAVI |  QUANTUM |  UNION |  ITI |  MAHINDRA MANULIFE |  360 ONE |  BOI |  TAURUS |  JM FINANCIAL |  PGIM |  SHRIRAM |  BARODA BNP PARIBAS |  QUANT |  WHITEOAK CAPITAL |  TRUST |  SAMCO |  NJ

ABOUT GROWW